Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
134,5 EUR | -0,22% | +1,36% | +43,70% |
Omzet 2024 * | 292 mld. 41,91 mld. 39,06 mld. | Omzet 2025 * | 352 mld. 50,65 mld. 47,2 mld. | Marktkapitalisatie | 4.460 mld. 641 mld. 597 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 104 mld. 14,99 mld. 13,97 mld. | Nettowinst (verlies) 2025 * | 128 mld. 18,39 mld. 17,14 mld. | EV/omzet 2024 * | 15,4 x |
Nettoschuld 2024 * | 22,58 mld. 3,24 mld. 3,02 mld. | Nettoliquiditeiten 2025 * | 5,93 mld. 852 mln. 794 mln. | EV/omzet 2025 * | 12,6 x |
K/w-verhouding 2024 * |
43,3
x | K/w-verhouding 2025 * |
35,2
x | Werknemers | 66.015 |
Dividendrendement 2024 * |
1,17% | Dividendrendement 2025 * |
1,44% | Vrij verhandelbaar | 70,22% |
Recentste transcriptie over Novo Nordisk A/S
1 dag | -0,22% | ||
1 week | +1,36% | ||
Lopende maand | +7,62% | ||
1 maand | +8,31% | ||
3 maanden | +13,03% | ||
6 maanden | +44,87% | ||
Lopend jaar | +43,70% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 58 | 01-01-91 | |
Director of Finance/CFO | 53 | 01-01-99 | |
Stephen Gough
CTO | Chief Tech/Sci/R&D Officer | - | 01-10-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sylvie Grégoire
BRD | Director/Board Member | 62 | 19-03-15 |
Helge Lund
CHM | Chairman | 61 | 23-03-17 |
Martin MacKay
BRD | Director/Board Member | 68 | 01-03-18 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-06-24 | 134,5 | -0,22% | 8 835 |
27-06-24 | 134,8 | -0,03% | 4 129 |
26-06-24 | 134,8 | -1,99% | 5 429 |
25-06-24 | 137,6 | +3,91% | 5 437 |
24-06-24 | 132,4 | -0,59% | 2 765 |
uitgestelde koers Deutsche Boerse AG, 28 juni 2024 om 18:18 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,32% | 819 mld. | |
-6,75% | 351 mld. | |
+13,56% | 329 mld. | |
+10,68% | 298 mld. | |
+16,57% | 242 mld. | |
+2,04% | 225 mld. | |
+13,31% | 217 mld. | |
+8,48% | 168 mld. | |
-2,81% | 158 mld. |
- Beurs
- Aandelen
- Koers NOVO B
- Koers NOV